Mike A. Leonis, William F. Balistreri – 19 October 2005

Margaret V. Ragni, Bijan Eghtesad, Kimberly W. Schlesinger, Igor Dvorchik, John J. Fung – 19 October 2005 – Despite improved survival after liver transplantation (OLTX) in HIV‐positive individuals treated with highly active antiretroviral therapy (HAART), some transplant candidates do not survive to OLTX. To determine if pretransplant outcome is related to severity of liver disease and/or HIV infection, we prospectively evaluated 58 consecutive HIV‐positive candidates seen at a single center from 1997‐2002.

Ryoko Honda, Yasuharu Ohno, Takuya Iwasaki, Sadayuki Okudaira, Masahiko Okada, Akira Kamitamari, Koichi Ohshima, Hiroyuki Moriuchi, Takashi Kanematsu – 19 October 2005 – We report a case of Langerhans' cell histiocytosis (LCH) occurring after a living donor liver transplantation (LDLT) for fulminant hepatitis. A 9‐month‐old girl underwent an LDLT for fulminant hepatitis of an unknown cause. The histology of the native liver did not show any findings of LCH. On postoperative day 42, her Epstein‐Barr virus (EBV)‐DNA and cytomegalovirus antigenemia were both found to be positive.

Timothy M. McCashland – 19 October 2005

Kareem M. Abu‐Elmagd, Vijayan Balan – 19 October 2005

Michael Charlton – 19 October 2005

James Neuberger – 19 October 2005

Adrian M. Di Bisceglie – 19 October 2005

Andres T. Blei – 19 October 2005

5 October 2005